{"id":"NCT01263509","sponsor":"Takeda","briefTitle":"Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan","officialTitle":"A Long-term, Open-label Extension Study to Investigate the Long-term Safety of SYR-322 When Used in Combination With α-glucosidase Inhibitor in Subjects With Type 2 Diabetes in Japan","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2007-06","primaryCompletion":"2008-10","completion":"2008-10","firstPosted":"2010-12-20","resultsPosted":"2011-08-29","lastUpdate":"2012-02-03"},"enrollment":179,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Alogliptin and voglibose","otherNames":["SYR-322","Voglibose","BASEN®"]},{"type":"DRUG","name":"Alogliptin and voglibose","otherNames":["SYR-322","Voglibose","BASEN®"]}],"arms":[{"label":"Alogliptin 12.5 mg QD and Voglibose 0.2 mg TID","type":"EXPERIMENTAL"},{"label":"Alogliptin 25 mg QD and Voglibose 0.2 mg TID","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to evaluate the long-term safety and efficacy of alogliptin and an α-glucosidase inhibitor administered once daily (QD) or three times daily (TID) for 40 consecutive weeks in participants who completed a phase 2/3 α-glucosidase inhibitor add on study.","primaryOutcome":{"measure":"Number of Participants With Adverse Events.","timeFrame":"52 Weeks.","effectByArm":[{"arm":"Alogliptin 12.5 mg QD and Voglibose 0.2 mg TID","deltaMin":6,"sd":null},{"arm":"Alogliptin 25 mg QD and Voglibose 0.2 mg TID","deltaMin":7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"33 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22106975"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":108},"commonTop":["Nasopharyngitis","Upper respiratory tract inflammation","Back pain","Bronchitis","Diarrhoea"]}}